Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Indoco Remedies Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
Astrazeneca Pharma I 8718.05 426.55 5.14 80.36 108.49 1424-1.73 0.37 305.28
Onesource Specialty 1543.3 106 7.37 15.23 101.33 34961-1.29 0 516.29
Ajanta Pharma 2895.85 92.35 3.29 75.48 38.37 285010.44 0.97 289.84
Venus Remedies 1039.95 45.8 4.61 52.85 19.68 3665233.8 0 441.01
Glenmark Pharma 2194.05 31.15 1.44 0.74 2967.75 1749059.52 0.11 868.26
Acutaas Chemicals 2393.75 30.1 1.27 35.66 67.13 31582103.33 0.03 160.19
Emcure Pharma 1630.15 29.4 1.84 33.69 48.38 1710970.9 0.18 158.99
Procter&Gamble Healt 4972.65 29 0.59 176.81 28.12 693-4.75 2.51 320.52
Torrent Pharma 4179.05 21.75 0.52 64.97 64.32 1010729.58 0.77 224.32
Wockhardt 1362.15 18.1 1.35 11.75 115.88 41747-2.82 0 169.88
Eris Lifesciences 1388.05 17.75 1.3 20.44 67.92 31860.65 0.53 183.9
Glaxosmithkline Phar 2409.85 16.6 0.69 58.85 40.95 2517-16.23 2.24 115.94
CORONA Remedies 1575.9 16.1 1.03 24.37 64.67 494  0.46 99.04
Senores Pharmaceutic 836.45 13 1.58 2.99 279.34 1272448.68 0 153.74
Windlas Biotech 812.9 12.15 1.52 31.6 25.72 1137-24.06 0.71 238.81
Sudeep Pharma 621.4 11.1 1.82 8.48 73.3 4450  0 44.01
Akums Drugs & Pharma 524.45 8.95 1.74 7.88 66.55 145609.82 0 150.57
Wanbury 248.15 7.7 3.2 18.51 13.4 6549-3.05 0 15.69
Zydus Lifesciences 923.1 7.65 0.84 46.23 19.97 454774.4 1.19 210.64
Sanofi Cons. Health 4627.1 7.3 0.16 104.25 44.38 941-6.61 1.62 118.26
Page 1 of 9 Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.